Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Shares Issued (2020 - 2025)

Celularity (CELU) has disclosed Shares Issued for 6 consecutive years, with -$460000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued changed N/A to -$460000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.9 million, a 126.82% decrease, with the full-year FY2024 number at $58000.0, down 99.36% from a year prior.
  • Shares Issued was -$460000.0 for Q3 2025 at Celularity, down from $2.5 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $46.5 million in Q1 2022 to a low of -$16.5 million in Q4 2022.
  • A 5-year average of $3.0 million and a median of $312000.0 in 2021 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 7789.95% in 2022; the steepest drop was 4073.49% in 2022.
  • Celularity's Shares Issued stood at $415000.0 in 2021, then plummeted by 4073.49% to -$16.5 million in 2022, then skyrocketed by 152.73% to $8.7 million in 2023, then tumbled by 168.33% to -$5.9 million in 2024, then surged by 92.26% to -$460000.0 in 2025.
  • Per Business Quant, the three most recent readings for CELU's Shares Issued are -$460000.0 (Q3 2025), $2.5 million (Q1 2025), and -$5.9 million (Q4 2024).